Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

First Trust Materials AlphaDEX Fund (NY:FXZ)

66.39 +1.57 (+2.42%)
Official Closing Price Updated: 8:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about First Trust Materials AlphaDEX Fund

News headline image
Operational Challenges Slow Mosaic's Phosphate Division Progress ↗
Mosaic stock slides after mechanical and utility disruptions cut Q3 phosphate output to 1.7M tonnes, below expectations. 
Via Benzinga
News headline image
Chile Cuts Up To 70% Of Red Tape, Promises Streamlined Mining Approvals ↗
Chile's Congress passed a reform to cut mining permitting times, aiming to boost investor confidence in the top copper and lithium supplier. 
Via Benzinga
News headline image
Kore Potash Secures $2.2 Billion Term Sheet For Project In Republic of Congo ↗
Kore Potash secures $2.2 billion for Kola Project in Congo through non-binding term sheet agreement with OWI-RAMS, reducing equity dilution and increasing shareholder value. 
Via Benzinga
News headline image
CF Industries, JERA, Mitsui Form $4 Billion JV To Build Low-Carbon Ammonia Plant In Louisiana ↗
CF Industries forms JV with JERA and Mitsui for CO₂ capturing and low-carbon ammonia production. CF to hold 40%, JERA 35%, Mitsui 25% ownership. 
Via Benzinga
News headline image
Interior Secretary Calls For 'Mine, Baby, Mine,' Promising Cost Savings From Deregulation ↗
 
Via Benzinga
News headline image
Celanese Analysts Brace For Tough 2025 As Price Cuts Pile Up ↗
Celanese Corporation shares are trading lower on Thursday after several analysts slashed price forecasts following Q4 earnings. 
Via Benzinga
News headline image
FMC's Dividend In Danger? Analyst Warns Of Debt Pressures And Credit Downgrade Risks ↗
FMC's stock dips after weak Q4 results and lowered outlook. Analyst downgrades and predicts dividend cut due to debt and competition concerns. 
Via Benzinga
News headline image
Nucor's Q4 Guidance Misses The Mark, Hit By Steel Slowdown; Stock Slides ↗
Nucor expects lower fourth quarter EPS due to decreased volumes and lower average selling prices in the steel mills segment. However, raw materials segment is anticipated to see an increase in... 
Via Benzinga
News headline image
Cleveland-Cliffs Doubles Down on Steel with $2.5B Acquisition, Expects $120M in Annual Savings ↗
Cleveland-Cliffs to acquire Stelco Holdings Inc. for CAD70/share, valuing Stelco at 4.8x LTM Adjusted EBITDA. Deal expected to boost EPS and expand Cliffs' steelmaking footprint in North America. 
Via Benzinga
News headline image
FMC Cleans Up Portfolio With GSS Sale, Eyes Debt Reduction and Goes Green ↗
FMC signed a $350M deal to sell its Global Specialty Solutions business to Envu, aiming to reduce debt. Transaction expected to close by 2024. 
Via Benzinga
News headline image
US Steel And CarbonFree Forge Path For Carbon Capture Innovation At Gary Works Blast Furnaces ↗
U.S. Steel pioneers carbon capture deal at Gary Works, aiming to slash emissions and meet sustainability goals. 
Via Benzinga
Topics Emissions
News headline image
A Materials World? ↗
An analysis of the three largest materials sector ETFs and a few of the stocks they hold. 
Via Talk Markets
News headline image
U.S. Stocks Log Worst Q1 In Two Years: Top-Ranked ETFs Shine ↗
Wall Street wrapped up its worst performance in two years thanks to the ongoing conflict in Ukraine and its inflationary effect on prices. While there have been many losers, here we highlight five ETFs... 
Via Talk Markets
News headline image
Q1 Earnings Effect: 5 Must-Watch ETF Charts ↗
Here are five ETFs that have buoyed up on strong earnings results. 
Via Talk Markets
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.